- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0078449

About Inbiosys Systems Private Limited
Data last updated:
Inbiosys Systems Private Limited is a private limited company based in Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 25 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC341068. Its GSTIN is 07AAFCI0442Q1ZC (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Paathak and Neelam Pathak.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 461 Kh. No. 172 3rd Floor, Rithala Rohini, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.89 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹8.29 Lakh (net margin 1.4%) and EBITDA of ₹22.2 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 13% over five years.
As per MCA filings, the company has open charges of ₹1.55 Cr on record.
Inbiosys Systems Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0078449). For more details, the company can be reached via its website inbiosyssystems.com.
Company details
Recognitions & Rankings of Inbiosys Systems
Contact details
Inbiosys Systems Private Limited's registered office is in Delhi, Delhi. Its website is inbiosyssystems.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressHouse No. 461 Kh. No. 172 3rd Floor, Rithala Rohini, Delhi, India – 110085
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Inbiosys Systems Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inbiosys Systems is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Inbiosys Systems Private Limited, buy the company report.
Financials of Inbiosys Systems Private Limited
FY 2025 filings availableInbiosys Systems Private Limited reported revenue of ₹5.89 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 10% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹5.89 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.29 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inbiosys Systems Private Limited, buy the company report.
Board of directors of Inbiosys Systems Private Limited
Inbiosys Systems has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Paathak | Director | 25 Oct 2018 | 8 Years 0 Months | Current |
| Neelam Pathak | Director | 25 Oct 2018 | 8 Years 0 Months | Current |
Peer comparison
Inbiosys Systems Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tec Pharma Systems India Private Limited | ₹5.94 Cr (FY 2024) | 122.0% | Hyderabad, Telangana, India | |||
| Arya Scientific Instruments Private Limited | ₹5.93 Cr (FY 2025) | -7.0% | Ambala Cantt, Haryana, India | |||
| Inbiosys Systems Private Limitedthis company | ₹5.89 Cr (FY 2025) | ₹8.29 Lakh | 1.4% | 10.0% | Delhi, India | |
| Symbiotic Meditech Indore Private Limited | ₹5.89 Cr (FY 2025) | 575.0% | Indore, Madhya Pradesh, India | |||
| BVM Meditech Private Limited | ₹5.88 Cr (FY 2025) | -34.0% | Delhi, India | |||
| HCS Medicals Private Limited | ₹5.86 Cr (FY 2025) | -40.0% | Gurgaon, Haryana, India |
To see the full peer comparison of Inbiosys Systems Private Limited, buy the company report.
Auditor
Inbiosys Systems Private Limited is audited by R R SINHA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R R SINHA & ASSOCIATES | FY 2023 | 023531N |
Shareholding
The shareholding of Inbiosys Systems Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Inbiosys Systems Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jan 2026 | 101263979 | Others | ₹1 Cr | Open | |
| 22 Jul 2024 | 100959726 | Hdfc Bank Limited | ₹55 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Inbiosys Systems Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inbiosys Systems Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inbiosys Systems has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCI0442Q1ZC | Delhi | Active | 10 Jan 2019 |
To see the full GST registrations and return filing status of Inbiosys Systems Private Limited, buy the company report.
Recent activity
Inbiosys Systems Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Amit Paathak was appointed as Director on 25 Oct 2018.
Frequently asked questions
Inbiosys Systems is an active private limited company based in Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 25 October 2018 (8+ years old) and is registered under CIN U74999DL2018PTC341068.
Inbiosys Systems has 2 current directors:
- Amit Paathak - Director
- Neelam Pathak - Director
The latest financial statements of Inbiosys Systems on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Inbiosys Systems is 07AAFCI0442Q1ZC, registered in Delhi.
The CIN (Corporate Identification Number) of Inbiosys Systems is U74999DL2018PTC341068. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inbiosys Systems was incorporated on 25 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Inbiosys Systems by revenue are Tec Pharma Systems India Private Limited, Arya Scientific Instruments Private Limited, Symbiotic Meditech Indore Private Limited, BVM Meditech Private Limited, HCS Medicals Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Amit Paathak was appointed as Director on 25 Oct 2018. Neelam Pathak was appointed as Director on 25 Oct 2018.
Yes, Inbiosys Systems is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0078449).
Inbiosys Systems can be reached through the website inbiosyssystems.com. Its registered office is in Delhi, India.
The registered office of Inbiosys Systems is at House No. 461 Kh. No. 172 3rd Floor, Rithala Rohini, Delhi, India – 110085.